Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : License entities : X financial save search
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China
Published: 2022-01-28 (Crawled : 11:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 4.35%
H: 0.0%
C: -4.87%
aup-16 urea gene therapy license therapeutics disease cel one china therapy collaboration diabetic diabetes
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
Published: 2022-01-03 (Crawled : 19:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 1.33%
H: 4.26%
C: 2.62%
at04 affitope license cholesterol immunotherapy china therapy biotech iot hypercholesterolemia
X Financial Obtains National Online Microcredit Business Operating License
Published: 2021-05-26 (Crawled : 10:00) - prnewswire.com
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 1.56%
H: 6.65%
C: 6.15%
license
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
SENS | $0.3992 -4.04% 0.45% 2M
|
Electronic Technology
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
DV | News | $29.43 -2.36% 0.24% 1.9M
|
Information
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
RIO | $66.97 0.43% 0.19% 2.7M
|
Non-Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.